| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 22828-05-3 | H-Phe-Asp-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 2 | 150398-22-4 | H-Phe-Arg-Arg-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | 42538-40-9 | H-Phe(2-Br)-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 4 | 14486-13-6 | H-Met-Val-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 5 | 13589-04-3 | H-Met-Tyr-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 6 | 154938-34-8 | H-Met-Trp-Tyr-Arg-Pro-Asp-Leu-Asp-Glu-Arg-Lys-Gln-Gln-Lys-Arg-Glu-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 7 | 14517-43-2 | H-MET-SER-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 8 | 142702-34-9 | H-Met-Pro-OH·HCl |
≥98% | | 询价 |
| 9 | 14492-14-9 | H-Met-Phe-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 10 | 14492-15-0 | H-Met-Phe-Gly-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 11 | 13404-22-3 | H-Ala-OtBu,HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 12 | 5557-83-5 | H-Ala-Obzl,HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 13 | 4244-84-2 | H-b-Ala-OEt,HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 14 | 68858-21-9 | HMP-Linker |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 15 | 74124-79-1 | DSC |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 16 | 145013-05-4 | Bis-Boc-thiourea |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 17 | 2334434-49-8 | PF-06815345 HCl |
≥98% | | 询价 |
| 18 | 2215931-60-3 | PCSK9 degrader 1 |
≥98% | | 询价 |
| 19 | | TQB-3823 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 20 | 1401683-39-3 | Senaparib(IMP-4297)HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 21 | 1401682-78-7 | Senaparib(IMP-4297) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 22 | 2055357-65-6 | JPI-547 HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 23 | 2055357-64-5 | JPI-547 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 24 | 2170491-77-5 | AMXI-5001 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 25 | 1681017-83-3 | Venadaparib(IDX-1197) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 26 | 1510829-06-7 | Vecabrutinib |
≥98% | | 询价 |
| 27 | 133152-67-7 | SI-60 |
≥98% | | 询价 |
| 28 | 2479465-67-1 | Ebola and Marburg Entry Inhibitor |
≥98% | | 询价 |
| 29 | 72236-23-8 | DCBA |
≥98% | | 询价 |
| 30 | 656830-24-9 | camphorataanhydride A |
≥98% | | 询价 |
| 31 | 2379438-80-7 | Neuraminidase-IN-1 |
≥98% | | 询价 |
| 32 | 248281-84-7 | Laquinimod(ABR-215062) |
≥98% | | 询价 |
| 33 | 1850385-64-6 | AZD9977 |
≥98% | | 询价 |
| 34 | 1404-93-9 | Vancomycin HCl |
≥98% | | 询价 |
| 35 | 84408-37-7 | Desciclovir |
≥98% | | 询价 |
| 36 | 1130067-34-3 | CAY10594 |
≥98% | | 询价 |
| 37 | | TASP0415914 |
≥98% | | 询价 |
| 38 | 1125632-93-0 | Takeda-6d |
≥98% | | 询价 |
| 39 | 870223-96-4 | AMG-Tie2-1 |
≥98% | | 询价 |
| 40 | 1003311-62-3 | AMG-25 |
≥98% | | 询价 |
| 41 | 1144107-80-1 | CY5,5 carboxylic acid |
≥98% | | 询价 |
| 42 | 1191911-26-8 | CZC-25146 freebase |
≥98% | | 询价 |
| 43 | 528-50-7 | D-(+)-Cellobiose |
≥98% | | 询价 |
| 44 | 1333327-56-2 | TRC051384 |
≥98% | | 询价 |
| 45 | 1265965-22-7 | S-49076 |
≥98% | | 询价 |
| 46 | 1997319-84-2 | SGC-SMARCA-BRDVIII |
≥98% | | 询价 |
| 47 | 210304-20-4 | TLR7/8 agonist |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 48 | 111466-62-7 | [14C]-Orlistat |
≥98% | | 询价 |
| 49 | 1400742-42-8 | BB-22 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 50 | 1105542-94-6 | Budesonide-d8 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 51 | 168158-16-5 | KB-R7785 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 52 | | BMS-986339 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 53 | 25486-55-9 | Vitamin K1 2,3-Oxide(vitamin K epoxide) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 54 | 24696-26-2 | C16 Ceramide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 55 | 1788063-52-4 | GDC-0310 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 56 | 1129540-33-5 | Paclitaxel-d5 |
≥98% | | 询价 |
| 57 | 323176-64-3 | WAY-303290 |
≥98% | | 询价 |
| 58 | 1807758-81-1 | SIRT7 inhibitor 97491 |
≥98% | | 询价 |
| 59 | 2409964-23-2 | LOX-IN-3 dihydrochloride |
≥98% | | 询价 |
| 60 | 2253744-56-6 | TH-5427 |
≥98% | | 询价 |
m.cnreagent.com